CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Quince Therapeuticks Inc - QNCX CFD

0.8232
2.5%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0295
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 0.8443
Open 0.8344
1-Year Change -40.77%
Day's Range 0.8223 - 0.8356
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 28, 2024 0.8232 -0.0112 -1.34% 0.8344 0.8374 0.8156
May 24, 2024 0.8443 -0.0100 -1.17% 0.8543 0.8627 0.8250
May 23, 2024 0.8577 -0.0215 -2.45% 0.8792 0.9040 0.8446
May 22, 2024 0.8673 0.0194 2.29% 0.8479 0.9025 0.8479
May 21, 2024 0.8527 -0.0215 -2.46% 0.8742 0.8742 0.8526
May 20, 2024 0.8711 -0.0260 -2.90% 0.8971 0.9177 0.8711
May 17, 2024 0.8768 -0.0173 -1.93% 0.8941 0.9625 0.8767
May 16, 2024 0.9054 0.0113 1.26% 0.8941 0.9215 0.8941
May 15, 2024 0.8888 -0.0053 -0.59% 0.8941 0.9174 0.8749
May 14, 2024 0.8925 -0.0046 -0.51% 0.8971 0.9539 0.8925
May 13, 2024 0.8906 -0.0471 -5.02% 0.9377 0.9377 0.8906
May 10, 2024 0.9319 0.0377 4.22% 0.8942 0.9423 0.8742
May 9, 2024 0.8943 -0.0026 -0.29% 0.8969 0.9109 0.8943
May 8, 2024 0.8893 -0.0140 -1.55% 0.9033 0.9169 0.8843
May 7, 2024 0.9045 -0.0685 -7.04% 0.9730 0.9770 0.8934
May 6, 2024 0.9462 -0.0069 -0.72% 0.9531 0.9671 0.9291
May 3, 2024 0.9696 0.0563 6.16% 0.9133 0.9867 0.9133
May 2, 2024 0.9233 -0.0267 -2.81% 0.9500 0.9730 0.9232
May 1, 2024 0.9715 -0.0754 -7.20% 1.0469 1.0469 0.9670
Apr 30, 2024 1.0569 0.0200 1.93% 1.0369 1.0769 1.0169

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Cortexyme Inc. Company profile

About Cortexyme Inc

Cortexyme, Inc. is a clinical stage biopharmaceutical company that is focused on providing disease-modifying therapeutics to treat Alzheimer's and other degenerative diseases. The Company provides 3CLpro inhibitor, COR803 product, is a lead compound for treatment of coronavirus infections. The Company’s products pipeline includes drug candidates for the treatment of central nervous system (CNS) disorders including Alzheimer’s disease; for the treatment of oncology applications including the prevention of oral squamous cell carcinoma, and for the treatment of underserved and chronic conditions such as periodontitis. The Company’s COR388 is for the treatment of Alzheimer’s disease and Parkinson's disease. The Company's COR588 is in Phase I clinical trial and targeting to use in the treatment of periodontal disease and other P. gingivalis-related indications. The Company is also developing COR588, is a second-generation brain penetrant lysine gingipain inhibitor.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Cortexyme Inc revenues was not reported. Net loss increased 17% to $89.9M. Higher net loss reflects Stock-based Compensation in R&D increase from $7M to $15.1M (expense), Stock-based Compensation in GA increase of 99% to $14.8M (expense), General and administrative - Balancing increase of 45% to $14.7M (expense).

Industry: Biotechnology & Medical Research (NEC)

601 Gateway Boulevard, Suite 1250
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

News

Gold and Silver recover from last week’s pullback but face resistance ahead of US PCE

Gold and Silver move higher after last week’s pullbacks but the precious metals are struggling with resistance ahead of the US PCE release.

15:46, 28 May 2024

Copper price slumps as traders take profits, where to next?

Copper price drops over 5% on Thursday as traders take profits following the FOMC meeting minutes.

16:17, 24 May 2024

Market analysis: EUR/GBP driven by diverging policy expectations

The EURGBP is driven by the question: which cuts first, the ECB or the BOE? Currently, swaps markets (chart below) imply that it will be the ECB (blue line).

13:46, 24 May 2024

UK CPI Preview: Will inflation return to 2% as the BoE predicts? And how will it affect GBP?

The latest round of inflation data will be released at 22 April at 7 am BST and investors are likely going to be paying close attention.

15:44, 21 May 2024

Reserve Bank of New Zealand Preview: RBNZ could become more dovish as inflation eases and growth softens

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, May 22, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

15:29, 21 May 2024

Nvidia Q1 Earnings Preview: Analysts forecast another blockbuster set of results

Nvidia (NVDA) reports its Q1 results after the closing bell on Wednesday, May 22nd. We preview what to expect from Nvidia’s earnings and analyse its stock's technicals.

14:57, 21 May 2024
CPI, consumer price index symbol.

Disinflation resumes in the US as CPI drops in April

The rate of growth in US consumer prices dropped in April leading markets to price in more chances of rate cuts from the Fed

11:24, 16 May 2024

People also watch

Oil - Crude

80.31 Price
+0.210% 1D Chg, %
Long position overnight fee 0.0090%
Short position overnight fee -0.0309%
Overnight fee time 21:00 (UTC)
Spread 0.030

BTC/USD

67,790.90 Price
-0.640% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

18,757.60 Price
-0.700% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

XRP/USD

0.53 Price
-0.170% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading